Abstract

Both neutralization and antibody-dependent cellular cytotoxicity (ADCC) may be required for effective protection against HIV-1 infection. While there is extensive information on the targets of early neutralizing antibody (nAb) responses, much less is known about the targets of ADCC responses, which are more difficult to characterize. In four individuals recruited during acute HIV-infection, ADCC responses were detected 3–7 weeks prior to nAb responses. To determine the relative influence of ADCC and nAb responses on virus evolution, we performed an in-depth investigation of one individual (CAP63) who showed the highest nAb and ADCC responses. Both nAbs and ADCC antibodies targeted the V4 region of the Env, although there were some differences in epitope recognition. We identified accelerated viral evolution in this region concurrent with emergence of nAb activity, but not ADCC activity. Deep sequencing demonstrated that most nAb escape mutations were strongly selected for, however one nAb escape mutation that rendered the virus highly susceptible to autologous ADCC responses, was suppressed despite not affecting viral fitness. This escape mutation also rendered the virus more sensitive to autologous responses, as well as monoclonal antibodies targeting CD4-induced epitopes, compared to the wildtype virus. In conclusion, ADCC responses and nAbs in donor CAP63 recognized overlapping but unique epitopes in the V4 region, and while ADCC activity was present prior to nAbs, it did not drive viral evolution during this time. However, ADCC responses may select against nAb escape pathways that expose other common ADCC epitopes thereby restricting viral replication and expansion.

Highlights

  • Both neutralization and effector cell functions, mediated through the antibody Fc domain, may be required for effective protection against HIV-1 infection [1]

  • We first explored the kinetics of binding antibody and antibody-dependent cellular cytotoxicity (ADCC) development in four HIV-1 infected individuals (CAP45, CAP63, CAP210, and CAP239) recruited within 2 to 4 weeks postinfection (WPI), all of whom were infected by a single HIV-1 subtype C variant [16]

  • This study showed that viruses with neutralizing antibody (nAb) escape mutations that exposed CD4i epitopes resulting in increased ADCC sensitivity, were controlled

Read more

Summary

Introduction

Both neutralization and effector cell functions, mediated through the antibody Fc domain, may be required for effective protection against HIV-1 infection [1]. The effector function antibody-dependent cellular cytotoxicity (ADCC), investigated in this study, mediates NK cell killing of HIV-1 infected cells through the binding of antigenantibody complexes to the FcγRIIIa receptor (CD16) expressed on NK cells [3] These responses play a role in curbing early SIV viral replication [4,5,6], are enriched in human HIV-1 infected non-progressors [7], and may contribute to protection from HIV-1 infection, as suggested by the results of the HIV-1 RV144 vaccine trial [8,9,10,11]. ADCCmediating, non-neutralizing antibodies in breast milk have been correlated with reduced vertical transmission from viremic mothers [12] It is not known if ADCC responses play a role in the early control of HIV-1 infection, information that would be informative for vaccine design and antibody-based therapeutic studies

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call